TNFRSF8/CD30 Antibody (MMAE)

SKU: orb1805473

Description

Anti-TNFRSF8 / CD30 Reference Antibody and Monomethyl auristatin E (MMAE) that inhibits CD30-positive cells and is used for the study of relapsed and refractory Hogkin's lymphoma.

Images & Validation

−

Item 1 of 3

Tested Applications	ELISA, FA, FACS, In vivo
Reactivity	Human

Key Properties

−

Antibody Type	Recombinant Antibody
Clonality	Recombinant
Target	TNFRSF8 / CD30
Source/Expression System	CHO
Molecular Weight	145.48 kDa
Purity	>95%
Purification	Protein A
Endotoxin	<0.001 EU/ug
Conjugation	MMAE

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Buffer/Preservatives	100 mM Proline/Acetic acid 20mM Arginine pH 5.0
Concentration	Batch dependent
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

The purity of Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin)is more than 98.99% ;determined by SEC-HPLC.

Immobilized human CD30 His at 2 μg/mL can bind Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin);EC50=0.006007μg/mL.

Quick Database Links

Gene Symbol

TNFRSF8 / CD30

UniProt

P28908

UniProt Details

−

No UniProt data available

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

FACS

Fluorescence-Activated Cell Sorting (FC, Flow cytometry)

View Protocol

ELISA

Enzyme-linked Immunosorbent Assay (EIA)

View Protocol

Find More Protocols